Ingevity Corp Files 2024 10-K
Ticker: NGVT · Form: 10-K · Filed: 2025-02-19T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, chemicals
TL;DR
Ingevity filed its 2024 10-K. Check financials for FY24.
AI Summary
Ingevity Corp filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, operates in the Chemicals & Allied Products sector. Its principal executive offices are located at 4920 O'Hear Avenue, Suite 400, North Charleston, SC.
Why It Matters
This filing provides a comprehensive overview of Ingevity Corp's financial performance, operations, and risk factors for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard annual report and does not inherently indicate elevated risk without further analysis of its contents.
Key Numbers
- 2024 — Fiscal Year (The period covered by the 10-K filing.)
- 20250219 — Filing Date (The date the 10-K was submitted to the SEC.)
Key Players & Entities
- Ingevity Corp (company) — Filer of the 10-K
- 20250219 (date) — Filing date of the 10-K
- 20241231 (date) — Fiscal year end for the report
- 4920 O'Hear Avenue, Suite 400, North Charleston, SC 29405 (location) — Company's business and mailing address
- 8437402300 (phone_number) — Company's business phone number
FAQ
What is the primary business of Ingevity Corp?
Ingevity Corp operates in the Chemicals & Allied Products sector, as indicated by SIC code 2800.
When did Ingevity Corp's fiscal year 2024 end?
Ingevity Corp's fiscal year 2024 ended on December 31, 2024.
Where is Ingevity Corp headquartered?
Ingevity Corp's principal business and mailing address is 4920 O'Hear Avenue, Suite 400, North Charleston, SC 29405.
What is the SEC file number for Ingevity Corp?
The SEC file number for Ingevity Corp is 001-37586.
On what date was this 10-K filing submitted?
This 10-K filing was submitted on February 19, 2025.
From the Filing
0001653477-25-000015.txt : 20250219 0001653477-25-000015.hdr.sgml : 20250219 20250219161855 ACCESSION NUMBER: 0001653477-25-000015 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 174 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250219 DATE AS OF CHANGE: 20250219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 25640304 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 10-K 1 ngvt-20241231.htm 10-K ngvt-20241231 false 2024 FY 0001653477 P0D http://fasb.org/us-gaap/2024#OtherOperatingIncomeExpenseNet http://fasb.org/us-gaap/2024#OtherOperatingIncomeExpenseNet http://fasb.org/us-gaap/2024#OtherOperatingIncomeExpenseNet P1Y http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2024#LongTermDebtCurrent http://fasb.org/us-gaap/2024#LongTermDebtCurrent http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations iso4217:USD xbrli:shares iso4217:USD xbrli:shares ngvt:segment xbrli:pure ngvt:mmbtus ngvt:lease ngvt:claim 0001653477 2024-01-01 2024-12-31 0001653477 2024-06-30 0001653477 2025-02-14 0001653477 2023-01-01 2023-12-31 0001653477 2022-01-01 2022-12-31 0001653477 2024-12-31 0001653477 2023-12-31 0001653477 us-gaap:CommonStockMember 2021-12-31 0001653477 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001653477 us-gaap:RetainedEarningsMember 2021-12-31 0001653477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001653477 us-gaap:TreasuryStockCommonMember 2021-12-31 0001653477 2021-12-31 0001653477 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001653477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001653477 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001653477 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001653477 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001653477 us-gaap:CommonStockMember 2022-12-31 0001653477 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001653477 us-gaap:RetainedEarningsMember 2022-12-31 0001653477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001653477 us-gaap:TreasuryStockCommonMember 2022-12-31 0001653477 2022-12-31 0001653477 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001653477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001653477 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001653477 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001653477 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001653477 us-gaap:CommonStockMember 2023-12-31 0001653477 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001653477 us-gaap:RetainedEarningsMember 2023-12-31 0001653477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001653477 us-gaap:TreasuryStockCommonMember 2023-12-31 0001653477 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001653477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001653477 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001653477 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-31 0001653477 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001653477 us-gaap:CommonStockMember 2024-12-31 0001653477 us-gaap:AdditionalPaidInCapitalMember 202